Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Source filing unavailable
Q4 2020 · —
Revenue$318.05M$318.05M−3.2% vs Q4 2019 Net Income$23.73M$23.73M+41.0% vs Q4 2019 EPS Diluted$1.09$1.09+39.7% vs Q4 2019 Gross Profit$112,680,000−7.2% Operating Income$26,570,000+2.0% Operating Cash Flow$51,320,000
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
+29.9%
Free Cash Flowderived$37,292,000+165.3% Margins · derivedGross margin35.4%−1.5 pt vs Q4 2019
Operating margin8.4%+0.4 pt vs Q4 2019
Net margin7.5%+2.3 pt vs Q4 2019